https://www.statnews.com/2022/10/28/patient-death-lecanemab-alzheimers-trial/

ARIA brain swelling no joke can be fatal! ARIA cases are impossible to monitor in real world application outside clinical trial scenario.

No volume. Almost closing match still below 1m shares traded today.

@RWLV :)

https://sg.yahoo.com/style/katy-perry-addresses-fan-theories-063107939.html

ATK small fish swimming behind the whales trying to eat some of their leftover crumbs. Stay humble in the stock market. Once traders get cocky and try to do some macho stunts, the market has a way of teaching them a lesson and make them poorer. Always be a humble student of the market.

Taokay, you think my house backyard trees grow money? ATK financially weakened after preparing for Taurx warrant exercise. Im not actively trading this stock means good news for the real big whales. My observation of price action is generally not too bad. I accumulate together when the whales are collecting and sell when I think they are selling. So far my hit rate success for this stock is abt 80%. My trades are not small, ranging from 1.5m to 3m shares. Whales really hate nibble and sharp traders that can swing large trade sizes, always spoiling their party during their accumulation and distribution phases. Zero sum game in stock trading hence Im also eating some of the whale's lunch. Burp! Sometimes I cannot say too much here, the whales need to have their lunch too. Stay nibble in this treacherous stock market and dont end up being the lunch! There is some element of luck too! 70% own effort, 30% teekong luck. Popi Popi.... :p

KLCI green and GenS potential good news for Q3 result but GenB hardly moving up. Maybe gaming/tourism industry sector not in play now.

Posted by choysun > 28 minutes ago | Report Abuse
@ATK So new cha cha round?
------------------------------------------------------

No la. Just sharing some good news with Genting comrades. Financially draining to exercise Taurx warrants hence taking a rest first. Hopefully not for long :p

*Singapore Gaming – Flash Notes on MBS 3Q22 Results*
_Impressive Gaming Revenue Recovery To >90% Of Pre-Pandemic Levels_

• *MBS: Stellar gaming volume recovery.* MBS’s adjusted EBITDA surged 2187% yoy to US$343m (best Q since pandemic). 3Q22 net gaming revenue has also recovered 4% qoq to 94% of pre-pandemic levels. In S$, 3Q22’s mass market (table and slot) GGR rose 156% yoy and 10% qoq, while VIP GGR surged 1221% yoy and 4% qoq. Mass:VIP GGR mix for tables (ie excluding slots) stood at 50%:50% in 3Q22 (2Q22: 48%:52%).

• *Mass market: Further qoq recovery lifted by resilient mass volume.* In S$, we estimate that the mass market non-rolling chip volume further recovered and rose 12% qoq to represent the highest quarter since COVID-19 (90% of pre-pandemic levels), while slot handle improved 10% qoq to historical high and exceeds pre-pandemic levels. With higher mass volumes at +10% qoq despite flattish win rate, mass table GGR surged 13% qoq while slot GGR surged 7% qoq in 3Q22. The overall mass market GGR improved 10% qoq.

• *VIP: RCV recovered close to pre-pandemic levels, but lower win rate.* We estimate MBS' 3Q22 RCV rose 29 qoq (+1504% yoy) and represented 96% of pre-pandemic levels, mainly due to strong international visitations following Singapore’s lifting of borders restrictions. Despite a lower win rate of 3.47% in 3Q22 (2Q22: 4.29%), VIP GGR increased 4% qoq and spiked 1221% yoy (mainly reflecting steep recovery from lackluster foreign patronage during SG’s borders closure in 3Q21).

• *RWS: Expecting a similarly better quarter with remarkable gaming volume recovery.* We expect Resorts World Singapore (RWS) to deliver positive GGR trajectory, although RWS’ volume dynamics will trail MBS’ to partly reflect reduced hotel capacity. With gaming revenue significantly recovering in 3Q22 in tandem with the influx of international visitors to Singapore following removal of most pandemic-related restrictions, RWS will also benefit from Singapore’s overall pent-up tourism demand in 3Q22 which will lift its hotel occupancy and average room rates.

• *Maintain OVERWEIGHT and we look forward to China’s eventual borders reopening.* We retain our view that China’s eventual border reopening remains as a strong rerating catalyst for Singapore’s gaming industry. To recap, China visitors historically make up about 19-20% of Singapore’s pre-pandemic tourist arrival in 2018-19. Moving forward, we expect China to ease travel restrictions from 4Q22-1Q23 onwards, and its travel pent-up demand may allow both MBS and RWS to potentially deliver above pre-pandemic GGR.

• *Maintain BUY on GENS with target price of S$1.08,* which implies 8x 2023F EV/EBITDA (-0.5SD below mean). We continue to expect cash flushed GENS (net cash accounts for 33% of market cap) to engage in significantly better capital management moving forward and offers attractive prospective yield of 5.1-5.8% in 2023F.

@Michael, for Maybank that was 2009 la. Time flies. Ha! :p

You predict interest rate a few years later even higher? A few months later yes easy to ptedict, a few yrs later nope.

Thanks Choysun. Im also gauging the secondary pricing / trading activity of Taurx shares to see if there is opportunity for trades.

Be cautious of Dow's dead-cat-bounce as we are in bear market. Fierce bear rallies / short coverings do happen from time to time.

Posted by choysun > 1 hour ago | Report Abuse
Wah, Futures up crazy again. So who managed to accumulate last few days? Cha cha @ATK? :p
----------------------------------------------------

Busy with Taurx warrant exercise now. Painful to exchange S$ and ringgit into US$ now. Lucky I have some US$ exchanged at lower rate parked in account earlier this year. Warrant exercise price US$45 each, now market price US$200 to $300. This one can make 400% profit. So I better watch and focus action on this important basket of eggs over the next couple of months.

Posted by Stocksafeplayer > 2021-04-26 17:00 | Report Abuse
I bought some today cos worry next week is start of May.....before goes back to 5.0 again....Heng ahh!!
------------------------
Posted by WinSSP > 3 hours ago | Report Abuse
so happy busy collecting….happy week ahead everyone!
------------------------------------------------------------------


Really ah? OK lor.... Kekeke.....

.

Posted by stkoay > 32 minutes ago | Report Abuse
Copied and paste from Contract Statement.
------------------------------------------------------

Taokay, there is a Chinese saying "real gold not scared of fire". We are not fake investor/ trader :p

Posted by DestinyL > 4 days ago | Report Abuse
Still havn't fully bought back from previous selling when Taurx surged at RM5++
-------------------------------------------------------

Congratulations to your cha cha profits @DestinyL :)

Posted by stkoay > 3 hours ago | Report Abuse
I sold some of this at 4.91 on 19-7-21 and switched to Maybank at 8.02.
Now, Maybank (plus 3 dividends since then 28+30+28) is 9.31
This one plus dividend 18 is 4.50...
Which is more profitable?
Boring? Haha.......
------------------------------------

Wow! Taokay an accomplished cha cha dancer too. Even better, change venue to hotter dance hall! :)

https://www.theedgemarkets.com/article/genting-may-get-raise-shareholding-taurx-cheap-%E2%80%94-maybank-ib-research

Post removed.Why?

Posted by AngTayKor > 5 days ago | Report Abuse

Sibei soong.... today up big again....... $$$$$ (each $=rm100,000/= profits)
For professional cha cha dancers, safety always come first. Haha :)

------------------------------------------------------
Posted by WinSSP > ---- | Report Abuse
Haha, don’t listen to fake, unlicensed TR KS ATK…. This is only public chat forum.
Ai yo yo, TR KS ATK posted made porfeet….when Red. Profits made only when Green, faham tak?


************************************
COME INTO MY TRADING ROOM
************************************

CONTRACT(S) CD TRANS DATE DUE DATE CONT.NO TYPE SECURITY NAME QUANTITY TRD. CCY PRICE GROSS
AMOUNT NET AMOUNT DEBIT NET AMOUNT CREDIT SETTLEMENT CCY : MYR

MY07/10/22 12/10/22 655025/700/01 SELL GENTING, 3182 1,430,000 MYR 4.60608 6,586,694.40 6,574,122.76
Comm (SR) Other Fee (NS) Foreign Fee (NS) Ex. Rate
9,880.04 0.00 2,000.00 0.30510

MY07/10/22 12/10/22 655003/700/01 SELL GENTING, 3182 570,000 MYR 4.55684 2,597,398.80 2,591,450.75
Comm (SR) Other Fee (NS) Foreign Fee (NS) Ex. Rate
3,896.10 0.00 1,779.22 0.30510


************************************

TOTAL SOLD = 2,000,000 SHARES

.

Posted by MoneyMakers > 1 week ago | Report Abuse
Walao AngTK everyday say alot seller/foreign seller/fed crash market blablabla
Suddenly today say enter 4.3 (after price up)..u think anyone believe meh
Really ridiculous story aiyoyo
------------------------------------------------------------------------------------------

************************************
COME INTO MY TRADING ROOM
************************************

CONTRACT(S)
CD TRANS DATE DUE DATE CONT.NO TYPE SECURITY NAME QUANTITY TRD. CCY PRICE GROSS AMOUNT
NET AMOUNT DEBIT NET AMOUNT CREDIT SETTLEMENT CCY : MYR

MY26/09/22 28/09/22 391892/400/01 BUY GENTING, 3182 926,600 MYR 4.33576 4,017,515.22 4,025,963.33
Comm (SR) Other Fee (NS) Foreign Fee (NS) Ex. Rate
6,026.27 0.00 2,000.00 0.31370

MY29/09/22 03/10/22 458918/400/01 BUY GENTING, 3182 353,400 MYR 4.40396 1,556,359.46 1,560,324.33
Comm (SR) Other Fee (NS) Foreign Fee (NS) Ex. Rate
2,334.54 0.00 1,466.91 0.31330

MY04/10/22 06/10/22 580652/400/01 BUY GENTING, 3182 150,000 MYR 4.46667 670,000.50 672,276.86
Comm (SR) Other Fee (NS) Foreign Fee (NS) Ex. Rate
1,005.00 0.00 1,201.01 0.31000

--------------------

MY26/09/22 28/09/22 392887/400/01 BUY GENTING, 3182 340,000 MYR 4.32765 1,471,401.00 1,475,204.03
Comm (SR) Other Fee (NS) Foreign Fee (NS) Ex. Rate
2,207.10 0.00 1,441.43 0.31370

MY27/09/22 29/09/22 428345/400/01 BUY GENTING, 3182 230,000 MYR 4.33348 996,700.40 999,599.12
Comm (SR) Other Fee (NS) Foreign Fee (NS) Ex. Rate
1,495.05 0.00 1,299.02 0.31350

**************************************

TOTAL BOUGHT = 2,000,000 SHARES

.

This was posted by ATK 4 months ago. Spot on analysis.

------------------------------------------------------------------

Posted by AngTayKor > 2022-06-05 01:14 | Report Abuse

Wait... I spotted something strange. Taurx is phrasing the words like this: "decline at a rate substantially less than is typical in Alzheimer’s based on published research."

This statement means that Taurx is comparing their active dose patient's performance in Lucidity trial VS the historical average score for all the placebo patients' for all the previous phase 3 clinical trials done by all other drug companies. I have been attending Taurx's AGMs every year, I have seen this term being used in Taurx's AGM's slides and I am able to comprehend what this announcement statement's phrasing actual meaning.

If Taurx is comparing their active dose's patient performance VS their own trial placebo patient group like in a phase 3 clinical trial scenario, the sentence phrasing should be read as: "decline at a rate substantially less than the trial's placebo patient group."

My personal view is that most likely Lucidity's placebo patient group somehow strangely has a stronger performance when compared to the historical average performance of all the previous phase 3 trials placebo patient group. Lucidity's placebo patient group is receiving the first generation MTC formula in very low dose. This is to make the real active dose pill and the placebo fake pill look and taste exactly the same, including for possible urine discolouration side effects. 18 years ago when I invested in Taurx, private equity investors will joking call this the "Blue Pee Pill". I think there could be some minority cases of minor positive drug effect here even at low dose MTC formula. It is very difficult to formulate a placebo fake pill that looks, taste and pee out in blue like the real pill.

Now I think the real trial result to be announced is going to be below my expected trial result score. This placebo pill become active dose is not a new issue. Taurx experienced this problem before back in 2016 when placebo pill HMTM 4mg was later discovered to be an active dose with powerful drug effects. Because of this placebo pill issue, the entire phase 3 clinical trial failed. I have mentioned abt this before in my earlier post. At that time, Taurx failed to realise that HMTM is actually 60 times the power of MTC formula. They thought its was like 30% more powerful than MTC. Some gross miscalculation then, very painful lesson learned, US$200m trial cost burned just like that, lost 6 years of drug development time.

Post removed.Why?

Posted by 1invest1 > 1 hour ago | Report Abuse
AngTayKor may have bought low sold high
Sure made profits.
If bought low 4.32, sold low 4.48, profit
If he bought 4.36, sold low 4.48, profit
He can read stk & situation well
--------------------------------------------

It is true that ATK bought plenty at 4.32 to 4.34. None was bought at the precise low of 4.31 because my buy q at that level didnt get hit 2 weeks ago.

But ATK "safety first" this morning, plenty from opening 4.64 to 4.69. You saw those very few volume done today at 4.69? Those were sold by yours truly here. Precision charting, precision timing, dare to strike at the right moment.

Posted by choysun > 2 hours ago | Report Abuse
The way I read it, effectiveness of drug was good. Just can't reference placebo since it's not possible to create the blinded test environment. Ok la, wait for approval :)
--------------------------------------------------------

Yes the result was way below my expectations for pre-specified endpoints. But it was above my expectation that MCI patients on the average can improve cognition and functional scores. The is called disease reversal. For mild and moderate patients, able to halt the disease is within my expectation.

All the trial patients have AD (brain scanned for amyloid deposits even though Lucidity is a Tau based trial). No way AD patients can score better or stop cognition decline if the drug does not work. Under such an outcome due to TAP (Therapeutic Active Placebo) issues, any JV licensing deals with big pharmas will have to wait until Taurx finishes the extra open label 12 mth extension with all the full data. Everyone will want to be on the cautious side. As I mentioned this morning abt the 3 ways of securing regulatory approvals, I believe Taurx shd be able to secure Conditional Marketing Approval to start commercialising HMTM but the authorities will need Taurx to conduct another larger and longer duration confirmation trial.

Posted by choysun > 1 hour ago | Report Abuse
Congratulations to cha cha profits
----------------------------------------------------

Choysun is a sharp observer also. A professional also. Check back the records.


---------------------------------------------


Posted by choysun > 1 week ago | Report Abuse
Reversal time :)
-------------------------------------------


Good price action observation @Choysun. Ever considered to become a career professional cha cha dancer? :p

Fierce bear market trade long also can profit. Not so simple. Precision in timing is everything. Precision timing is the best friend to the professional cha cha dancers.

ATK going to take a well deserved break. Going for a swim and drink my orange juice by the poolside.

Posted by WinSSP > 11 minutes ago | Report Abuse
Ai yo yo, TR KS ATK posted made porfeet….when Red. Profits made only when Green, faham tak?
---------------------------------------------------------

Aiyo got people really so dumb meh? Typical sour grapes la..... Smart traders bought low from 4.32 onwards. Now price still 4.49, how not to make profit? Real low average buy price mah, not those fake investor's 4.50, 4.20, 4.00, 3.50 type of auto dropping average buy price. So simple but still cannot understand? Anyway, safety first OK? Understand??? Huat Huat Huat Ah!!! $$$$$

Post removed.Why?

If Aduhelm can be FDA approved even without completing both trials (Biogen stopped the trials halfway thru), what do you think?

For professional cha cha dancers, safety always come first. Haha :)

Sibei soong.... today up big again....... $$$$$ (each $=rm100,000/= profits)

**************************************************************
ABLE TO REVERSE DISEASE PROGRESSION (MCI PATIENTS)
**************************************************************

In the 105 participants with MCI (baseline MMSE score 23) receiving the 16 mg/day dose, there was statistically significant cognitive improvement of 2 units over the pre-treatment baseline at 6 months (p=0.0002), 12 months (p=0.0391) and 18 months (p=0.0473) on the ADAS-cog13 scale. The mean change on the instrumental activities of daily living subscale of ADCS-ADL also remained above the pre-treatment baseline at 6, 12 and 18 months.

**************************************************************************
ABLE TO HALT DISEASE PROGRESSION (MILD & MODERATE PATIENTS)
***************************************************************************
In the 147 participants with mild to moderate AD (baseline MMSE 20) receiving 16 mg/day, there was a 2.5 unit cognitive decline in the first 9 months and no further decline over the following 9 months. The functional decline on the ADCS-ADL scale was -2 units at 12 months and -3 units at 18 months representing a reduction in decline of about 75% relative to a published meta-analysis of publicly available placebo decline data from historical trials in mild to moderate AD

There are 3 types of approval:

1. Pre-specified endpoints.

2. Biomarkers. For Aduhelm FDA was using reduction in amyloid deposits. For taurx case, rate of brain atrophy us being used. Rate of brain volume atrophy is the scientifically best measurement to prove drug efficacy because AD patients' brains will all shrink due to dying brain cells.

3. When pure placebo is unfeasible (as seen in taurx's case), use ADNI historical placebo patients' performance for all the previous clinical trials done. There is ready pool of data probably 10k of placebo patients for all the past decades of AD clinical trials

There is no way Taurx is able to do double-blinded trial patients due to harmless blue pee side effects for our clinical trials without causing Therapeutic Active Placebo (TAP).

4.56 now!!! OMG

4.55 now. Genting comrades Huat Huat Huat Ah! :p

Posted by WinSSP > 48 minutes ago | Report Abuse
Totally agree @emsvsi. Happy to hold & collect more at 3.5
-------------------------------------------------------------------------

Rm3.50? You can wait long long la. Look at the price action now. Its bullish, the immediate trend is up! Huat!!! :)

Posted by WinSSP > 14 seconds ago | Report Abuse
ATK kao sai …… Thanks for sharing useful comments by WinSSP. Huat ah
--------------------------------------------------------------------------

Caught in the act so many times. The evidence are here. Can some kind soul please email to feedback@i3investor.com to suspend her?

Posted by WinSSP > 12 minutes ago | Report Abuse
ATK kao sai again? Thanks for sharing useful comments by WinSSP. Huat ah!

-----------------------------------------------------------------------------------------

Which comments of yours had been ever useful? Dont think too highly of yourself la. Read again the historical records.

Right at the beginning of a major price collapse after ATK has warned everyone on 09/06/2022 morning, you were still in delusion of GentB M&A at high price on that afternoon. What a joke! Hahaha.....

Prompt warning was given by ATK just before the imminent collapse of share price back on 09/06/2022:


Posted by AngTayKor > 2022-06-09 01:01 | Report Abuse
KIEN HUAT INTERNATIONAL LIMITED (a substantial shareholder) disposed 2,692,500 shares on 08-Jun-2022.
KIEN HUAT REALTY SDN BERHAD (a substantial shareholder) disposed 3,026,800 shares on 07-Jun-2022.
KIEN HUAT REALTY SDN BERHAD (a substantial shareholder) disposed 2,357,700 shares on 03-Jun-2022.
KIEN HUAT REALTY SDN BERHAD (a substantial shareholder) disposed 1,200,000 shares on 02-Jun-2022.
KIEN HUAT INTERNATIONAL LIMITED (a substantial shareholder) disposed 20,000,000 shares on 07-Jun-2022.


OMG what is LKT doing??? Really unexpected!
----------------------------------------------------------------------------------------------------------

Posted by WinSSP > 2022-06-09 11:33 | Report Abuse
Interesting to see that resorts world’s cruises is registered in Singapore & that genting snowpark is remained unlisted….I guess if any tycoon wanted to takeover genting group, probably their first target is GB, mother share….so, it’s good news for confident investors but bad news if investors are not confident.
-----------------------------------------------------------------------------------------------------------


AngTayKor > 2022-06-09 15:58 | Report Abuse

Of course better for professional cha cha dancers. 4 rounds of successful GenB trades this year.

Posted here last night that LKT selling his GenB shares in large volumes daily. Smart traders would have cleared their balance this morning. The fake investor whose average prices can auto drop can even give delusional talk abt M&A of GenB at high price.

Need to remember history lessons. Rm5.20 zone better becareful thats where LKT started dumping in massive volume 4 months ago.

Those not onboard yet, its still not too late to join in the party tmr. Lets huat together! Cha cha cha!

Yes taokay, sibei shiok ah.... at night sleeping also money raining down. Haha

https://www.wsj.com/articles/u-n-calls-on-fed-other-central-banks-to-halt-interest-rate-increases-11664809202

Dow futures super green now. Huat! :)

The trend is up now hence ATK still buying the dips. Rm3.50 can wait forever, maybe next yr, maybe at bottom of bear market, maybe wont ever come again. But let me make more money first now. Any wishful thinking shd be banished in stock trading. The market is always right so just be fluid follow the trend n make the money now. This is the professional cha cha dance.

Posted by AngTayKor > 4 hours ago | Report Abuse

Result already good as per 1st June announcement. Now doing peer review of detailed clinical trial data by 8 renowned neuro professors to be published in JPAD medical journal prevention alzheimer's disease. JPAD is the official journal of CTAD
----------------------------------------------------

See 3rd page, 2nd paragraph.

"The LUCIDITY trial is designed to confirm the efficacy of HMTM* and support regulatory submission as the first disease modifying Alzheimer’s treatment for Mild Cognitive Impairment and Mild-to-Moderate stages. The trial background and design are described in an upcoming paper in the Journal of Prevention of Alzheimer’s Disease (JPAD)."

https://ts-assets.ams3.cdn.digitaloceanspaces.com/mg/tx/pdfs/Lucidity-Data-Announcement.31May2022.for-website.pdf


https://www.jpreventionalzheimer.com/about-the-journal.html

-------------------------
Posted by AngTayKor > 1 day ago | Report Abuse
Lets wait for presentation of full lucidity results at CTAD conference. Taurx session on 30/11 @11.30am San Francisco time.

Go and search it yourself.

https://www.ctad-alzheimer.com/

Result already good as per 1st June announcement. Now doing peer review of detailed clinical trial data by 8 renowned neuro professors to be published in JPAD medical journal prevention alzheimer's disease. JPAD is the official journal of CTAD

@DestinyL, no point trying to find out what is the cause of the price movement. Observing the price action is more important. (100 years ago it was known as the "ticker tape reading"). This was written by my stock trading grandmaster:


"The Message of the Tape: The fluctuations were from the first associated in my mind with upward or downward movements. Of course there is always a reason for fluctuations, but the tape does not concern itself with the why and wherefore. It doesn’t go into explanations. I didn’t ask the tape why when I was fourteen, and I don’t ask it today, at forty. The reason for what a certain stock does today may not be known for two or three days, or weeks, or months. But what the dickens does that matter? Your business with the tape is now—not tomorrow. The reason can wait. But you must act instantly or be left."

Temasek is Singapore's national investment holding company but it is not a publicly listed company. There is no share price for Temasek.

Temasek is holding Taurx shares via V-Sciences Investment Pte Ltd. This entity did not participate in the rights cum warrant issue of Taurx on Nov 2021 hence on fully diluted basis, Temasek's V-Sciences Investment will be holding only abt 1.9% of Taurx.

Posted by Casual_Analyst > 19 minutes ago | Report Abuse

@AngTayKor Thanks for sharing the information. where do you find all these information? can share the source/link? I am very interested to read more about it.
--------------------------------------------------------

I hold 0.7% of Taurx shares and vested since their "Series A" fund raising 18 years ago. I have been following the developments in the AD field for over 18 years so my views are cumulation of 18 yrs of my knowledge abt drug development in AD field. Some may find my analysis useful, some may find them thrash. Some may find my analysis useful but still stay its thrash. Ha! Better to ownself trade stock ownself make profit. Im up big today. Shiok ah....

Posted by DestinyL > 10 minutes ago | Report Abuse

I don't quite believe GenB up has anything to do with Biogen/Taurx
--------------------------------------------------------------------

Alzheimer's theme play for all NYSE's AD stocks now spreading into Bursa. GentB is the biggest shareholder of Taurx. Taurx is the holy grail to AD. To be a good cha cha dancer, need to know FA (Fundamental Analysis) and TA (Technical Analysis). FA+TA= FATA ("Fa Ta" in Chinese).